Penn researchers stress the self-reports in JAMA Network Open don't prove the drug caused anything, but increased appetite topped the list despite trials pointing to nausea.
Recap by typeshit. Full story at Science Daily.
Both suppliers of compounded semaglutide and tirzepatide ingredients landed on the FDA import-alert list. Times Now also covers dosing mistakes with compounded vials.
The visits came in the country's largest healthcare system, with the trend credited to wellness influencers and young people among those affected.
Researchers at the American Academy of Ophthalmology meeting found NAION patients on GLP-1 drugs tended to develop it in the other eye sooner.
MedPage Today
A mental health news roundup points to a New York Times report that patients with eating disorders have little protection as GLP-1 use grows.
Beauty companies are reportedly exploring products aimed at facial changes linked to rapid weight loss on GLP-1 drugs.
Bhekisisa reports illegal weight loss injections are still on sale, and the new rules meant to curb the trade are still months off.
Loading…